Inhibrx Biosciences, Inc. (INBX) vs Omeros Corporation (OMER)
Inhibrx Biosciences, Inc. and Omeros Corporation are both Biotechnology companies. Inhibrx Biosciences, Inc. and Omeros Corporation are of similar size ($1.5B and $1.5B). Inhibrx Biosciences, Inc. has negative trailing earnings, so its P/E is not meaningful; Omeros Corporation trades at 11.6×. Omeros Corporation has the higher net margin (128.4% vs 0.00%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, Omeros Corporation leads on 9 and Inhibrx Biosciences, Inc. on 5.
Valuation
Profitability
| Metric | INBX | OMER | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 37.57% | 65.16% |
| Operating margin | 0.00% | (74.88%) | 0.00% |
| Net margin | 0.00% | 128.36% | 0.00% |
| Free cash flow margin | 0.00% | (70.69%) | 0.00% |
| Return on equity | (1,773.60%) | (89.15%) | (57.72%) |
| Return on assets | (75.44%) | 51.22% | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack